Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 712869 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'Generics Series: Authorized Generics Analysis' returned 71 results - Page 1 of 4

  Sort by   
  Sorted by Rank Top-Bottom

U.S. Generic Pharmaceuticals Outlook  
Frost & Sullivan, April 2007, Pages: 66
This Frost & Sullivan research service titled U.S. Generic Pharmaceuticals Market Outlook provides a detailed analysis of this market, including competitive structure, market and revenue forecasts


Opportunities and Challenges for Bioequivalent Generic Drugs in Brazil  
Espicom Business Intelligence Ltd, April 2007, Pages: 190
throughout the country. About the Author: This report has been written by Espicom staff writer Ricardo Vicente. Ricardo has over 5 years market analysis experience in pharmaceuticals. He is the editor


The Pharmaceutical Market: Croatia  
Espicom Business Intelligence Ltd, Oct 2011, Pages: 48
, trade fairs, company intelligence and competitive strategies OTC PHARMACEUTICALS GENERIC PHARMACEUTICALS BIOLOGICS & BIOSIMILARS OPPORTUNITIES & CHALLENGES Espicom's unique strategic analysis


Pharmaceuticals - Global Outlook  
Global Industry Analysts, Inc., Sep 2008, Pages: 425
, Watson, Mallinckrodt, Alpharma, Qualitest, Par, Barr, Laboratories, and URL/Mutual 10 Generic Competition Provides the Necessary Momentum 11 Authorized Generics - A Major Concern for Generic Makers 11


The Pharmaceutical Market: Indonesia  
Espicom Business Intelligence Ltd, Oct 2011, Pages: 54
, trade fairs, company intelligence and competitive strategies OTC PHARMACEUTICALS GENERIC PHARMACEUTICALS BIOLOGICS & BIOSIMILARS OPPORTUNITIES & CHALLENGES Espicom's unique strategic analysis


The Pharmaceutical Market: Turkey  
Espicom Business Intelligence Ltd, Oct 2011, Pages: 82
PHARMACEUTICALS GENERIC PHARMACEUTICALS BIOLOGICS & BIOSIMILARS OPPORTUNITIES & CHALLENGES Espicom's unique strategic analysis DIRECTORY METHODOLOGY & SOURCES The Pharmaceutical Market: Turkey


Pharmaceutical Pricing and Reimbursement in Spain, 2008  
Decision Resources, Inc., Aug 2008, Pages: 34
Further Reference Pricing Modifi cations 22 Industry Response 22 Price Cuts 23 Sales Tax 23 Prescribing Controls 23 Patient Copayments 24 Prior Authorization 24 Promoting Greater Use of Generics 25


Urological Disorders Therapeutics to 2016 - Increasing Awareness and Aging Population will Drive the Benign Prostatic Hyperplasia and Urinary Incontinence Markets  
GBI Research, Aug 2010, Pages: 125
using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. The authors find that the urological disorders


The Pharmaceutical Market: South Korea  
Espicom Business Intelligence Ltd, Oct 2011, Pages: 60
MARKET ANALYSIS Projections, product development, manufacturing and trade COMPETITION Trade associations, trade fairs, company intelligence and competitive strategies OTC PHARMACEUTICALS GENERIC PHARMACEUTICALS


Emerging Markets Series: The Pharmaceutical Market of Saudi Arabia  
Datamonitor, June 2009, Pages: 123
project in Saudi Arabia Figure 25: Marketing Authorization process for generics, New Chemical Entities, biologics and orphan drugs Figure 26: The 11-digit Saudi National Drug Code Figure 27: Future


The Pharmaceutical Market: UK  
Espicom Business Intelligence Ltd, Oct 2011, Pages: 64
intelligence and competitive strategies OTC PHARMACEUTICALS GENERIC PHARMACEUTICALS BIOLOGICS & BIOSIMILARS OPPORTUNITIES & CHALLENGES Espicom's unique strategic analysis DIRECTORY METHODOLOGY & SOURCES


The Pharmaceutical Market: Hong Kong  
Espicom Business Intelligence Ltd, Oct 2011, Pages: 52
terms, Hong Kong will rank the fourth highest in the Asia Pacific region. Legally, although laws exist for IP protection, piracy is common in the country and the authorities find it hard to prosecute


The Outlook for Pharmaceuticals in South East Asia  
Espicom Business Intelligence Ltd, Nov 2011
expanding generic sectors, and present previously untapped populations for potential foreign pharmaceutical companies. Complete quarterly-updated analysis to keep you informed Now you can easily evaluate


Outlook of China Drug Formulation Market  
JZMed Inc., May 2011, Pages: 230
in drug formulation and the variety of dosage forms it can produce. Based on the in-depth analysis of a series of growth drivers and resistors that could affect the future development of this Chinese


The Pharmaceutical Market: Philippines  
Espicom Business Intelligence Ltd, Oct 2011, Pages: 56
The Generics Pharmacy DISTRIBUTION IN THE PUBLIC SECTOR MARKET ANALYSIS SIZE Projections Historical Figures PRODUCT DEVELOPMENT MANUFACTURING TRADE Exports Imports Parallel Imports Impact of Parallel


The Pharmaceutical Market: New Zealand  
Espicom Business Intelligence Ltd, Oct 2011, Pages: 62
is primarily the responsibility of New Zealand’s Medicines and Medical Devices Safety Authority (Medsafe). This authority regulates all products used for a therapeutic purpose, using the Medicines Act 1981


The Pharmaceutical Market: Serbia  
Espicom Business Intelligence Ltd, Oct 2011, Pages: 56
PHARMACEUTICALS GENERIC PHARMACEUTICALS BIOLOGICS & BIOSIMILARS Radar Analysis SWOT Analysis DIRECTORY GOVERNMENT ORGANISATIONS PHARMACEUTICAL PRODUCERS Foreign Pharmaceutical Producers Local Pharmaceutical


The Pharmaceutical Market: Malaysia  
Espicom Business Intelligence Ltd, Oct 2011, Pages: 60
PHARMACEUTICALS GENERIC PHARMACEUTICALS BIOLOGICS & BIOSIMILARS OPPORTUNITIES & CHALLENGES Espicom's unique strategic analysis DIRECTORY METHODOLOGY & SOURCES - Pharmaniaga - Zuellig Pharma - Apex


The Pharmaceutical Market: China  
Espicom Business Intelligence Ltd, Oct 2011, Pages: 100
GENERIC PHARMACEUTICALS BIOLOGICS & BIOSIMILARS OPPORTUNITIES & CHALLENGES Espicom's unique strategic analysis DIRECTORY METHODOLOGY & SOURCES - Allergan - Antibioticos - Astellas Pharma - Astra


The New Trend of API Sourcing and Contract Manufacturing in China  
JZMed Inc., Feb 2010, Pages: 158
and growth history of global merchant APIs (both generic drugs and innovative drugs) Table 18. Analysis of the contributions of Asian countries to the global merchant API industry Table 19. Chinese API


Results:  First -   Prev -   1 -   2 -   3 -   4 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds